PDF

07-Oct-2022

New Trinity Delta Research Report – New data draws attention to promising fibrosis assets

29-Jun-2022

New Trinity Delta Research Report – All the ingredients for success now in place

15-Jun-2022

New Trinity Delta Lighthouse Research Report – Jazz Pharmaceuticals $5m milestone triggered

07-Jun-2022

New Trinity Delta Lighthouse Research Report – £34.3m raise extends runway through key data points

30-Mar-2022

New Trinity Delta Research Report – RXC008 nominated as GI-ROCK drug candidate

17-Feb-2022

New Trinity Delta Research Report – Building on an impressive track-record

27-Jan-2022

New Trinity Delta Research Report – FY21 results: a year of continuing delivery

12-Oct-2021

Trinity Delta – R&D update: RXC004 and RXC007 in the spotlight

21-Sep-2021

New Trinity Delta Research Report – ESMO 2021: RXC004 monotherapy Phase I study results

07-Sep-2021

New Trinity Delta Research Report – ‘All that Jazz: $3m milestone boosts cash and confidence’